Contract Pharmaceutical News: Breaking Contract Pharmaceutical News, Comments and Articles. - Page: 5

Medicago Announces 2013 First Quarter Financial Results

QUEBEC CITY, May 9, 2013 /PRNewswire/ -   Medicago Inc. (TSX: MDG), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced its operational and financial results for the first quarter ended March 31, 2013. The Company's financial statements and management...

Unilife Corporation Announces Financial Results For Fiscal Year 2013 Third Quarter

YORK, Pa., May 9, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended March 31, 2013, (the third quarter of Fiscal Year 2013). Recent Highlights In April, Unilife signed a 15-year customization and commercial supply contract with...

Optimer Reports First Quarter 2013 Financial Results

JERSEY CITY, N.J., May 9, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today unaudited financial results for the first quarter ended March 31, 2013.   (Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO) Financial Highlights First quarter 2013 DIFICID net product sales in the U.S. and Canada of $16.8 million, compared to $14.4 million in 2012...

Verenium Reports Financial Results For The First Quarter Ended March 31, 2013

SAN DIEGO, May 9, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported financial results for the first quarter ended March 31, 2013, and also provided full year 2013 financial guidance. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO)...

Recipharm and Synthonics establish drug delivery technology agreement

Recipharm Pharmaceutical Development AB and Synthonics, Inc have established a Joint Promotion Agreement which will provide Recipharm customers with full access to Synthonics’ technology to improve the delivery and performance of Recipharm compound...

Aesica and University of Nottingham to develop novel amide chemical synthesis method

Contract manufacturing organisation Aesica has formed a partnership with the University of Nottingham for the commercial development of alternative methods in amide bond synthesis. The partnership has been established through the Aesica Innovation Bo...

Kemwell expands analytical services capabilities in India

To support a contract with large multinational pharmaceutical company

Comprehend Systems Named a Gartner Cool Vendor in Life Sciences

Leading IT Analyst Firm Highlights Cloud-based Data Insights Platform for Clinical Research Sponsors Comprehend Systems was named one of only five Gartner “Cool Vendors in Life Sciences, 2013” for its ability to offer clinical research sponsors unparalleled access to clinical and ope

Define Vendor Site Selection Strategy to Jump-Start Phase 1 Trials

Pharmaceutical companies often opt not to outsource clinical site selection to patient recruitment or site management organizations during Phase 1 clinical testing, according to a new study by Cutting Edge Information. Cutting Edge Information’s recent study, “Optimizing Clinical Pharmacology Programs: Cost-Drivers of Phase 1 Trials,” found...

Teamsters File Unfair Labor Practice Charge Against Osco

Company Violates Law By Firing 30-year Pharmacist and Teamster Negotiating Committee Member, Charge Says CHICAGO, May 9, 2013 /PRNewswire-USNewswire/ -- Teamsters Local 727 has filed unfair labor practice charges against Jewel-Osco after the company violated the National Labor Relations Act (NLRA) when it terminated Teamster pharmacist and bargaining committee member Harold Collier. ...

TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S, Copenhagen, Denmark

SAN DIEGO, May 9, 2013 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink, www.trilinkbiotech.com), a leader in manufacturing high quality oligonucleotides, nucleoside triphosphates and mRNA, announced that it has signed a licensing agreement with QuantiBact A/S (QuantiBact, www.quantibact.com) to offer twisted intercalating nucleic acid (TINA) modified oligos. TINA molecules are intercalator...

Coghlin Companies Certified as a Google Verified Supplier

WORCESTER, Mass., May 9, 2013 /PRNewswire/ -- Coghlin Companies, a privately held firm specializing in engineering design, contract manufacturing, global fulfillment, and aftermarket service solutions, has joined Google's business-to-business marketplace, Google Shopping for Suppliers, as a Verified Supplier. Coghlin Companies applied for the program after being invited, and a Google representativ...

Bioanalytical Systems to Release Second Quarter Results Wednesday, May 15, 2013; Conference Call & Webcast Set For 11:00 a.m. EDT

Bioanalytical Systems, Inc. (NASDAQ:BASI) will release financial results for the second quarter ended March 31, 2013 at approximately 8:30 a.m. EDT on Wednesday, May 15, 2013. BASi has scheduled a conference call at 11:00 a.m. EDT that morning to discuss its results for the quarter. To participate in the call, dial 866.515.2909, passcode #30217450....

BIOTONE to Exhibit at Beautyworld Middle East

BIOTONE Is Part of California Delegation at International Event BIOTONE announces its plans to exhibit at Beautyworld Middle East, May 28-30 in Dubai. Now in its 17th year, the show is the largest trade fair for beauty products, hair, fragrances and wellbeing in the Middle East. BIOTONE will be participatin

The MED Group Announces New Agreement with CareCentrix Effective May 1, 2013

LUBBOCK, Texas, May 9, 2013 /PRNewswire/ -- The MED Group, a Managed Health Care Associates, Inc. (MHA) Company, today announced a new agreement with home health benefits manager, CareCentrix, effective May 1, 2013, for a period of three years. CareCentrix is the leading provider of home health benefits management services to the health care industry, and has earned a reputation for excellence i...

Boehringer Ingelheim To Break Into Biologics Contract Manufacturing Market In China

Reporting 32% growth in China for 2012, BI will be the first Big Pharma to enter the biologics contract manufacturing space in the country.

MAXIMUS Reports Financial Results for Second Quarter of Fiscal 2013

- Company Reiterates Guidance - MAXIMUS (NYSE: MMS), a leading provider of government services worldwide, today reported financial results for its second quarter ended March 31, 2013. Highlights for the quarter ended March 31, 2013 include: Revenue grew 34% to $326.4 million for the second quarter compared to $243....

ABACHEM: Reliable Development and Manufacturing Service Provider

SHANGHAI, May 9, 2013 /PRNewswire/ -- ABACHEM is a public listed company in China, specializing in contract manufacturing to the pharmaceutical, biotechnological and agrochemical industries. Offering a broad spectrum of services for the production of fine chemicals, advanced intermediates and active pharmaceutical ingredients, we have successfully collaborated and partnered with major pharmaceutic...

Velammal Educational Trust Selects Accenture to Support its Healthcare Growth and Technology Strategy

Accenture (NYSE:ACN) has been awarded a technology consulting contract by Velammal Educational Trust (VET), a Tamil Nadu-based group of 25 educational institutes, to help it establish an integrated healthcare facility in the city of Madurai. The facility will be comprised of a medical college, teaching hospital and corporate hospital. Accen...

Accenture to help develop VET's integrated healthcare facility in Tamil Nadu, India

Accenture has been awarded a technology consulting contract by Velammal Educational Trust, a Tamil Nadu-based group of 25 educational institutes, to help it establish an integrated healthcare facility in the city of Madurai.

Global Earth Energy, Inc. (GLER) Announces Letter of Intent for Additional Asset; Purchase Contract for Sunrise Highway Office Building

WILMINGTON, N.C., May 9, 2013 (GLOBE NEWSWIRE) -- Global Earth Energy Inc.'s (GLER.OTCQB) President, Mr. Sydney A. Harland, announces that GLER, through a "Letter of Intent", intends to Acquire an additional asset; Country Road Office Building, located at, 1670 Old Country Road, Plainview, New York 11803. Currently under board review, this acquisition will only occur if GLER and the seller of the...

Sarepta Therapeutics Announces First Quarter 2013 Financial Results and Recent Corporate Developments

CAMBRIDGE, MA -- (Marketwired) -- 05/09/13 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today reported financial results for the three months ended March 31, 2013, and provided an update of recent corporate developments. "We are encouraged by our initial interactions with the U.S. Food and Drug Administration regarding a potential accelerated ap...

Orion Marine Group Announces a Contract Award of Approximately $9 Million

HOUSTON, May 9, 2013 (GLOBE NEWSWIRE) -- Orion Marine Group, Inc. (NYSE:ORN) (the "Company"), a leading heavy civil marine contractor serving the infrastructure sector, today announced a contract award of approximately $9 million. Orion Marine Group was recently awarded a contract by the US Army Corps of Engineers to dredge approximately two million cubic yards of material on a portion of the H...

TriLink signs TINA modified oligonucleotide licensing contract with QuantiBact

TriLink BioTechnologies has signed a licensing contract with QuantiBact for twisted intercalating nucleic acid (TINA) modified oligonucleotides.

GAO Dismisses Request for Reconsideration by ERBE Contractor, Supporting Previous Ruling in Favor of Bidder Offering US Medical Innovations, LLC’s Product

On May 6, 2013, the U.S. Government Accountability Office (GAO) dismissed a request for reconsideration of its recent decision regarding the award of a VA federal contract by the Department of Veterans Affairs (VA) in Veterans Healthcare Supply Solutions, Inc., B-407223.2, Dec. 13, 2012, 2012 CPD ¶ 3. The decision confirmed the GAO’s previous ruling in...